Maria Soloveychik
Signal active
Chief Executive Officer & Co-Founder
Contact Information
Social
Primary Organization
SyntheX
Founded
2016
Employees
11-50
Industry
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Bio
Maria Soloveychik and Charly Chahwan are working on curing untreatable cancer. They are disrupting the drug discovery cycle which typically takes $10m to $15m and upto 6 years. They have created compounds that have similar efficacy as other drugs and they were able to get to that stage in 2 months at the cost of $20,000 … I am going to let that sit with you. If that is not disruptive I am not sure what is.
Maria Soloveychik is the CEO and co-founder of SyntheX Labs, a biotech company developing peptide therapeutics for cancer and other rare diseases. SyntheX labs was part of IndieBio batch #3 in 2016. They have successfully raised seed capital to move their vision forward. It was exciting to talk to Maria, she embodies everything that is inspiring about a founder.
Location
San Francisco, California, United States, North America
Board and Advisor Roles
0
N/A
Educations
1
N/A
Profile Resume
Maria Soloveychik is the Chief Executive Officer & Co-Founder at SyntheX, based in United States, North America. With a background in Biotechnology, Maria Soloveychik has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity